Search research articles
Contact Us
Filters
Showing results (41-50 of 206) with videos related to
Page
of 21
Sort By:
Blood
|
August 15, 1995
Interleukin-6 family of cytokines and gp130
T Kishimoto, S Akira, M Narazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 1995
Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
H Hirota, K Yoshida, T Kishimoto, et al.
The Journal of Clinical Investigation
|
September 1, 1995
AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies
K Murakami-Mori, T Taga, T Kishimoto, et al.
International Immunology
|
April 1, 1996
The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth
K Murakami-Mori, T Taga, T Kishimoto, et al.
Biochemical and Biophysical Research Communications
|
June 26, 1995
Regulation of mouse soluble interleukin-6 receptor secretion by decidua
M Yamaguchi, A Mammoto, T Taga, et al.
Nucleic Acids Symposium Series
|
January 1, 1985
On the reactions of DL-1,3-dimethylthymine epoxide with amines and L-amino acid derivatives
T Harayama, R Yanada, T Taga, et al.
Cytokine
|
July 11, 2001
Astrocyte differentiation of fetal neuroepithelial cells involving cardiotrophin-1-induced activation of STAT3
W Ochiai, M Yanagisawa, T Takizawa, et al.
International Reviews of Immunology
|
January 1, 1989
Current concepts of B cell modulation
T Matsuda, K Yamasaki, T Taga, et al.
Chemical & Pharmaceutical Bulletin
|
August 1, 1990
Multiple binding of inhibitors in the complex formed by bovine trypsin and fragments of a synthetic inhibitor, 4-[4-(N,N- dimethylcarbamoxylmethoxycarbonylmethyl)phenoxycarbonylphenyl+ ++] guanidinium methanesulfonate (FOY-305)
O Matsumoto, T Taga, M Matsushima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
August 1, 1997
[Long-term follow up of idiopathic thrombocytopenic purpura in childhood]
T Taga, S Ohta, K Higashino, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 206) with videos related to
Sort By:
Page
of 21
Blood
|
August 15, 1995
Interleukin-6 family of cytokines and gp130
T Kishimoto, S Akira, M Narazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 1995
Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
H Hirota, K Yoshida, T Kishimoto, et al.
The Journal of Clinical Investigation
|
September 1, 1995
AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies
K Murakami-Mori, T Taga, T Kishimoto, et al.
International Immunology
|
April 1, 1996
The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth
K Murakami-Mori, T Taga, T Kishimoto, et al.
Biochemical and Biophysical Research Communications
|
June 26, 1995
Regulation of mouse soluble interleukin-6 receptor secretion by decidua
M Yamaguchi, A Mammoto, T Taga, et al.
Nucleic Acids Symposium Series
|
January 1, 1985
On the reactions of DL-1,3-dimethylthymine epoxide with amines and L-amino acid derivatives
T Harayama, R Yanada, T Taga, et al.
Cytokine
|
July 11, 2001
Astrocyte differentiation of fetal neuroepithelial cells involving cardiotrophin-1-induced activation of STAT3
W Ochiai, M Yanagisawa, T Takizawa, et al.
International Reviews of Immunology
|
January 1, 1989
Current concepts of B cell modulation
T Matsuda, K Yamasaki, T Taga, et al.
Chemical & Pharmaceutical Bulletin
|
August 1, 1990
Multiple binding of inhibitors in the complex formed by bovine trypsin and fragments of a synthetic inhibitor, 4-[4-(N,N- dimethylcarbamoxylmethoxycarbonylmethyl)phenoxycarbonylphenyl+ ++] guanidinium methanesulfonate (FOY-305)
O Matsumoto, T Taga, M Matsushima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
August 1, 1997
[Long-term follow up of idiopathic thrombocytopenic purpura in childhood]
T Taga, S Ohta, K Higashino, et al.
Page
of 21